It could take five to 10 years before the health industry fully understands “if, where and how” cannabis fits into the range of medicines used to treat patients, delegates at the Princess Alexandra Hospital Online Health Symposium have been told.

Queensland Health manager Tanya Bain said in the meantime, regulators and healthcare practitioners will continue to juggle the “fine line between patient expectation and evidence-based medicine”.

She added while the industry is still in its infancy, increasing doctor acceptance and a growing patient base are contributing to SAS-B approvals averaging around 9,000 since the start of the year.

Bain suggested the anticipated introduction of Queensland’s Medicines and Poisons Act 2019 this year will boost numbers still further.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh.
Avatar photo

Hannah Adler

Hannah is a communications professional and early-career researcher in the disciplines of health communication and health sociology. She is a PhD student at Griffith University currently writing a...

Leave a comment